The list ranks drugs by their annual cost for a typical course of therapy and are based on the drugs’ list prices.
The 10 most expensive drugs in the U.S., according to GoodRx:
- Zolgensma (Novartis) — $2,125,000
- Myalept (Amryt Pharma) — $855,678
- Luxturna (Spark Therapeutics) — $850,000
- Folotyn (Acrotech Biopharma) — $779,067
- Soliris (Alexion Pharmaceuticals) — $678,392
- Blincyto (Amgen) — $672,968
- Ravicti (Horizon Therapeutics) — $664,092
- Lumizyme (Sanofi) — $643,243
- Actimmune (Horizon Therapeutics) — $633,325
- Takhzyro (Takeda Pharmaceuticals) — $591,035
More articles on pharmacy:
CMS launches Part D plan to lower insulin costs
15 largest pharmacies in the US
Trump sends list of drug-pricing policy proposals to Capitol Hill
